Novel use for an EGFR mutation‐specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|6|816-823

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.6, 2015-05, pp. : 816-823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour‐to‐tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation‐specific antibodies

By  

HISTOPATHOLOGY, Vol. 67, Iss. 2, 2015-08 ,pp. : 262-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-11 ,pp. : 769-773

Karger

Access to resources Recommend Favorite

A Case of Micronodular Pneumocyte Hyperplasia Diagnosed through Lung Biopsy Using Thoracoscopy

By  

Respiration, Vol. 69, Iss. 3, 2002-06 ,pp. : 277-279

Karger

Access to resources Recommend Favorite

Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review

By  

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 510-518

Karger

Access to resources Recommend Favorite

Near Total Regression of Diffuse Brain Metastases in Adenocarcinoma of the Lung with an EGFR Exon 19 Mutation: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 445-451

Karger

Access to resources Recommend Favorite